Integrated Diagnostics Holdings (CAI:IDHC.CA) Change In Payables And Accrued Expense : E£0 Mil (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Integrated Diagnostics Holdings Change In Payables And Accrued Expense?

Integrated Diagnostics Holdings's Change In Payables And Accrued Expense for the quarter that ended in Jun. 2024 was E£0 Mil. It means Integrated Diagnostics Holdings's Accounts Payable & Accrued Expense stayed the same from Mar. 2024 to Jun. 2024 .

Integrated Diagnostics Holdings's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was E£0 Mil. It means Integrated Diagnostics Holdings's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Integrated Diagnostics Holdings Change In Payables And Accrued Expense Historical Data

The historical data trend for Integrated Diagnostics Holdings's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integrated Diagnostics Holdings Change In Payables And Accrued Expense Chart

Integrated Diagnostics Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Integrated Diagnostics Holdings Quarterly Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Dec23	Mar24	Jun24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Integrated Diagnostics Holdings Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was E£0 Mil.

Integrated Diagnostics Holdings Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Integrated Diagnostics Holdings's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Integrated Diagnostics Holdings Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integrated Diagnostics Holdings PLC (CAI:IDHC.CA) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

IDHCl:UK IDHC:UK

Address

IFC 5, Saint Helier, JEY, JE1 1ST

Website

https://www.idhcorp.com

Integrated Diagnostics Holdings PLC is active in the healthcare sector. It is a fully integrated diagnostics service provider, operating through brands such as Al Borg and Al Mokhtabar in Egypt, as well as Biolab in Jordan and Ultralab and Al Mokhtabar Sudan in Sudan, Echo-Lab in Nigeria; and Biolab KSA in Saudi Arabia. The company specializes in diagnostic tests, ranging from basic tests, such as glucose testing for diabetes, to molecular tests for hepatitis and specialized DNA tests. The company operates in two segments, Contract Segment which generates key revenue, and the Walk-in Segment. It derives a majority of its revenue from services offered in Egypt.

Integrated Diagnostics Holdings Headlines

No Headlines